According to a new report Asia Pacific mHealth Market, published by KBV research, the Asia Pacific mHealth Market would witness market growth of 32.7% CAGR during the forecast period (2020-2026).
The China market dominated the Asia Pacific Services Market by Country in 2019, and would continue to be a dominant market till 2026. The Japan market is experiencing a CAGR of 33.5% during (2020 - 2026). Additionally, The India market is poised to grow at a CAGR of 33.6% during (2020 - 2026).
The Mobile Operators market dominated the Singapore mHealth Market by Stakeholders in 2019, growing at a CAGR of 32.7 % during the forecast period. The Device Vendors market witnessing a CAGR of 32.9% during (2020 - 2026). The Healthcare Providers market is projected to grow at a CAGR of 35.3% during (2020 - 2026). Additionally, The Content Players market is estimated to grow at highest CAGR of 36.4% during (2020 - 2026).
The Cardiovascular Diseases market dominated the Malaysia mHealth Market by Applications in 2019, thereby, achieving a market value of $1,188.9 million by 2026. The Diabetes market is experiencing a CAGR of 34% during (2020 - 2026). The Respiratory market would exhibit a CAGR of 35.7% during (2020 - 2026). Additionally, The Neurology market would showcase CAGR of 35.2% during (2020 - 2026).
Structural Insights: https://www.kbvresearch.com/asia-pacific-mhealth-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Bayer AG, Medtronic PLC, Johnson and Johnson, Koninklijke Philips N.V., DexCom, Inc., Samsung Electronics Co., Ltd. (Samsung Group), Omron Corporation, AllScripts Healthcare Solutions, Inc., Sanofi S.A., Cerner Corporation.
By Type
By Services
By Devices
By Stakeholders
Content Players
By Country
Companies Profiled
Unique Offerings from KBV Research
Unique Offerings 
